Mstack Chemicals
United States
- Houston, Texas
- 04/10/2024
- Series A
- $40,000,000
Mstack is a specialist of tailor-made, high-demand specialty chemicals and intermediates that cater to the dynamic needs of various industries. With a well-established network of approved and dedicated production capacities in India, Mstack serves customers across diverse value chains. This includes providing intermediates and advanced intermediates for pharmaceutical APIs and agrochemical technicals, essential starting materials for dyestuffs, and intermediates for personal care ingredients, among others. Mstack facilitates global buyers in efficiently sourcing top-quality materials from India, ensuring both reliability and cost-effectiveness.
Mstack has been funded by global Tier-1 venture capital funds and have several renowned thought leaders and opinion shapers from the chemicals industry as advisors.
- Industry Chemical Manufacturing
- Website https://mstack.co/
- LinkedIn https://www.linkedin.com/company/mstack-inc/
Arycs Technologies | $24,000,000 | (Mar 13, 2026)
Ezra(2) | $8,000,000 | (Mar 13, 2026)
Freestyle | $10,000,000 | (Mar 13, 2026)
Mantis Space | $10,000,000 | (Mar 13, 2026)
Monteris Medical | $28,000,000 | (Mar 13, 2026)
Gumloop | $50,000,000 | (Mar 13, 2026)
Combat Medical Ltd | $3,472,639 | (Mar 13, 2026)
Qurrent | $15,000,000 | (Mar 13, 2026)
Waiv, formerly Owkin Dx | $33,000,000 | (Mar 13, 2026)
Carefam | $14,500,000 | (Mar 13, 2026)
Option Circle | $3,000,000 | (Mar 12, 2026)
AgentMail (YC S25) | $6,000,000 | (Mar 12, 2026)